CW
Insider selling
Conrad Wai sold $1.4M of Clover Health Investments, Corp. /De (CLOV) stock
Conrad Wai, CEO, Counterpart Health of Clover Health Investments, Corp. /De (CLOV), sold 300,000 shares of CLOV stock worth $1.4M, per an SEC Form 4 filed Sep 16, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 15, 2026, 1 day before it was made public.
CLOV has moved +2.6% since the trade date, from $4.66 to $4.78 (Oct 12, 2026 close).
- Traded
- Sep 15, 2026
- Disclosed
- Sep 16, 2026
- Filing delay
- 1 day
- Price since
- +2.6%
- Role
- CEO, Counterpart Health
- Source
- SEC Form 4
More CLOV insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.